 | Up a level |
Journal Article
Bloos, Frank 
ORCID: 0000-0002-0767-7941, Held, Juergen, Kluge, Stefan ORCID: 0000-0001-8391-3988, Simon, Philipp, Kogelmann, Klaus, de Heer, Geraldine, Kuhn, Sven-Olaf, Jarczak, Dominik ORCID: 0000-0003-0480-2089, Motsch, Johann, Hempel, Gunther, Weiler, Norbert, Weyland, Andreas, Druener, Matthias, Gruendling, Matthias, Meybohm, Patrick, Richter, Daniel, Jaschinski, Ulrich, Moerer, Onnen, Guenther, Ulf, Schaedler, Dirk, Weiss, Raphael, Putensen, Christian, Castellanos, Ixchel, Kurzai, Oliver, Schlattmann, Peter, Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Bauer, Michael and Thomas-Rueddel, Daniel
(2022).
(1 -> 3)-beta-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
Intensive Care Med., 48 (7).
S. 865 - 876.
NEW YORK:
SPRINGER.
ISSN 1432-1238
Bloos, Frank ORCID: 0000-0002-0767-7941, Held, Juergen, Schlattmann, Peter, Brillinger, Nicole, Kurzai, Oliver, Cornely, Oliver A. and Thomas-Rueddel, Daniel
(2018).
(1,3)-beta-D-glucan-based diagnosis of invasive Candida infection versus culturebased diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Trials, 19.
LONDON:
BMC.
ISSN 1745-6215
Hagel, Stefan ORCID: 0000-0003-2999-6131, Fiedler, Sandra, Hohn, Andreas, Brinkmann, Alexander, Frey, Otto R., Hoyer, Heike, Schlattmann, Peter, Kiehntopf, Michael, Roberts, Jason A., Pletz, Mathias W., Bloos, Frank, Angermair, Stefan, Bracht, Hendrik, Barth, Eberhard, Kluge, Stefan, Nierhaus, Axel, Motsch, Johann, Brenner, Thorsten, Annecke, Thorsten ORCID: 0000-0002-2496-4432, Bach, Friedhelm, Weigand, Markus, Schappacher, Markus, von Ameln-Mayerhofer, Andreas, Michels, Guido, Roehr, Anka, Fuchs, Thomas, Eichner, Sarah, Barth, Eberhard, Kong, Christina, Pinder, Nadine, Mueller, Carsten, Petersen, Miriam, Schlattmann, Peter, Steinbach, Gerald, Jarczak, Dominik, Weisman, Dirk, Kurlbaum, Max and Braune, Anke
(2019).
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Trials, 20.
LONDON:
BMC.
ISSN 1745-6215
Westermann, Isabella, Gastine, Silke ORCID: 0000-0002-1069-6123, Mueller, Carsten, Rudolph, Wiebke, Peters, Frank, Bloos, Frank ORCID: 0000-0002-0767-7941, Pletz, Mathias and Hagel, Stefan ORCID: 0000-0003-2999-6131
(2021).
Population pharmacokinetics and probability of target attainment in patients with sepsis under renal replacement therapy receiving continuous infusion of meropenem: Sustained low-efficiency dialysis and continuous veno-venous haemodialysis.
Br. J. Clin. Pharmacol., 87 (11).
S. 4293 - 4304.
HOBOKEN:
WILEY.
ISSN 1365-2125